MX2017002700A - Composicion farmaceutica para el tratamiento de dolor agudo de dientes o de mandibula. - Google Patents

Composicion farmaceutica para el tratamiento de dolor agudo de dientes o de mandibula.

Info

Publication number
MX2017002700A
MX2017002700A MX2017002700A MX2017002700A MX2017002700A MX 2017002700 A MX2017002700 A MX 2017002700A MX 2017002700 A MX2017002700 A MX 2017002700A MX 2017002700 A MX2017002700 A MX 2017002700A MX 2017002700 A MX2017002700 A MX 2017002700A
Authority
MX
Mexico
Prior art keywords
treatment
pharmaceutical composition
jaw pain
acute tooth
acute
Prior art date
Application number
MX2017002700A
Other languages
English (en)
Inventor
Hegewisch Alberto
Weiser Thomas
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of MX2017002700A publication Critical patent/MX2017002700A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere a una composición farmacéutica para administración oral para el tratamiento del dolor agudo de dientes o de mandíbula, que contiene ibuprofeno, cafeína y al menos un desintegrante.
MX2017002700A 2014-08-28 2015-07-23 Composicion farmaceutica para el tratamiento de dolor agudo de dientes o de mandibula. MX2017002700A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14002976 2014-08-28
PCT/EP2015/066888 WO2016030092A1 (en) 2014-08-28 2015-07-23 Pharmaceutical composition for the treatment of acute tooth or jaw pain

Publications (1)

Publication Number Publication Date
MX2017002700A true MX2017002700A (es) 2017-08-28

Family

ID=51535302

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002700A MX2017002700A (es) 2014-08-28 2015-07-23 Composicion farmaceutica para el tratamiento de dolor agudo de dientes o de mandibula.

Country Status (11)

Country Link
US (2) US20170252346A1 (es)
EP (1) EP3185861A1 (es)
JP (1) JP2017525774A (es)
CN (2) CN107205946A (es)
AU (1) AU2015309176B2 (es)
BR (1) BR112017003425A2 (es)
CA (1) CA2958454A1 (es)
EA (1) EA201790387A1 (es)
MX (1) MX2017002700A (es)
PH (1) PH12017500345A1 (es)
WO (1) WO2016030092A1 (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
CA2144152A1 (en) * 1992-09-29 1994-04-14 Robert T. Sims Ibuprofen-caffine combinations
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
JP4969747B2 (ja) * 2001-01-19 2012-07-04 武田薬品工業株式会社 錠剤フィルムコーティング用組成物
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
JP4710240B2 (ja) * 2004-03-31 2011-06-29 ゼリア新薬工業株式会社 医薬組成物
JP2005289905A (ja) * 2004-03-31 2005-10-20 Zeria Pharmaceut Co Ltd 医薬組成物
GB0417939D0 (en) * 2004-08-12 2004-09-15 Boots Healthcare Int Ltd Therapeutic agents
CN101068532B (zh) * 2004-09-30 2012-03-14 斯科尔医药公司 布洛芬改进释放剂型
US9066950B2 (en) * 2009-05-21 2015-06-30 Gm Pharmaceuticals, Inc. Analgesic compositions
TW201247195A (en) * 2011-04-28 2012-12-01 Kowa Co Stable pharmaceutical composition
WO2013031935A1 (ja) * 2011-08-31 2013-03-07 興和株式会社 安定な医薬組成物
DE202014104573U1 (de) * 2014-09-24 2014-12-05 DENK PHARMA GmbH & Co. KG Pharmazeutische Zusammensetzung zur Schmerzbehandlung

Also Published As

Publication number Publication date
EP3185861A1 (en) 2017-07-05
CN107205946A (zh) 2017-09-26
CN115721651A (zh) 2023-03-03
JP2017525774A (ja) 2017-09-07
AU2015309176B2 (en) 2020-12-03
US20170252346A1 (en) 2017-09-07
EA201790387A1 (ru) 2017-07-31
US20190269691A1 (en) 2019-09-05
CA2958454A1 (en) 2016-03-03
PH12017500345A1 (en) 2017-07-17
WO2016030092A1 (en) 2016-03-03
BR112017003425A2 (pt) 2017-11-28
AU2015309176A1 (en) 2017-03-16

Similar Documents

Publication Publication Date Title
PH12017502431A1 (en) Pharmaceutical formulations comprising tenofovir and emtrictabine
EP3349680A4 (en) METHOD FOR CREATING FLEXIBLE TOOTH TURNING MODEL FOR USE IN RESTAURANT DENTAL MEDICINE
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
ZA201903457B (en) Oral care composition and methods for whitening teeth
ZA201807745B (en) Personal dental care product for caries treatment
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2016006087A (es) Formulaciones de desintegracion rapida y metodos de uso.
RS60785B1 (sr) Kompozicija za oralnu upotrebu u lečenju gastroezofagealne refluksne bolesti ili nelagode
HK1255345A1 (zh) 含有高濃度紫杉烷的用於口服給藥的藥物組合物
PL3597141T3 (pl) Pilnik endodontyczny do stomatologicznego leczenia endodontycznego
HK1211891A1 (en) Oral and dental care and tooth cleaning agent
EP3773317C0 (en) SUBGINGIVAL SAFE END DENTAL BUR
ZA201800441B (en) Tooth whitening oral care composition
MX2018004532A (es) Combinacion de trazodona y gabapentina para el tratamiento de dolor.
PH12017500345A1 (en) Pharmaceutical composition for the treatment of acute tooth or jaw pain
SG11202101547WA (en) Pharmaceutical composition for oral administration
MX2017008516A (es) Anestesico a base de tetracaina.
GB2554484B (en) A dental formulation for the treatment of tooth sensitivity
PH12017500346A1 (en) Film coated tablet for the treatment of acute pain
IL240020A0 (en) Dental filling for the mouth or gums for aesthetic and reconstructive needs
MD20140128A2 (ro) Remediu igienic şi profilactic pentru îngrijirea dinţilor şi a cavităţii bucale
UA93055U (uk) Фармацевтична композиція для дентальної імплантації
MX2014008984A (es) Proceso de obtencion y composicion farmaceutica de fenofibrato capsulas como agente regulador de lipidos para su administracion oral.